Home  /  Resource Library  /  Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis

Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis

Meta analysis compared CART T therapies Axicabtagene ciloleucel with tisagenlecleucel for treatment of DLBCL.